TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6%
Fri, 31 Jul

TORRENT PHARMA has announced its results for the quarter ended June 2020. Here is a detailed performance review of the same:

TORRENT PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-19*
3
Mar-20*
3
Jun-20*
QoQ ChangeYoY Change
Net SalesRs m20,22019,46020,5605.7%1.7%
Other incomeRs m20015040-73.3%-80.0%
TurnoverRs m20,42019,61020,6005.0%0.9%
ExpensesRs m14,81013,98013,950-0.2%-5.8%
Gross profitRs m5,4105,4806,61020.6%22.2%
DepreciationRs m1,6001,6801,610-4.2%0.6%
InterestRs m1,2201,0201,0200.0%-16.4%
Profit before taxRs m2,7902,9304,02037.2%44.1%
TaxRs m630-21081028.6%
Profit after taxRs m2,1603,1403,2102.2%48.6%
Gross profit margin%26.828.232.1
Effective tax rate%22.6-7.220.1
Net profit margin%10.616.015.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 1.7% on a year-on-year (YoY) basis. The expenses were down by 5.8% YoY during the same period.
  • The company's operating profit increased by 22.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 32.1% in 1QFY21 as against 26.8% in 1QFY20.
  • Depreciation charges increased by 0.6% and finance costs declined by 16.4% YoY, respectively.
  • Other income declined by 80.0% YoY during the quarter.
  • Net profit for the quarter increased by 48.6% YoY. Net profit margins during the quarter increased from 10.6% in 1QFY20 to 15.6% in 1QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 5.7% on a quarter-on-quarter (QoQ) basis. The expenses were down by 0.2% QoQ during the same period.
  • The company's operating profit increased by 20.6% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 32.1% in 1QFY21 as against 28.2% in 4QFY20.
  • Net profit for the quarter increased by 2.2% QoQ, while net profit margins declined from 16.0% in 4QFY20 to 15.6% in 1QFY21.

To see how TORRENT PHARMA has performed over the last eight quarters,please visit here.

DISCOVER: How to Potentially Multiply Your Returns by Upto 5x...

TORRENT PHARMA Share Price Performance

Over the last one year,TORRENT PHARMA share price has moved up from Rs 1,669.3 to Rs 2,719.9, registering a Gain of Rs 1,050.6 or around 62.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 18,028.1 (up 2.0%). Over the last one year it has moved up from 12,704.4 to 18,028.1, a gain of 5,324 points (up 41.9%).

Overall, the S&P BSE SENSEX is up 0.6% over the year.

Current Valuations

At the current price of Rs 2,719.9, the price to earnings (P/E) ratio of TORRENT PHARMA stands at 40.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 9.7 times.

Equitymaster requests your view! Post a comment on "TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6%". Click here!

  

Related Views on News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Mar 5, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS